Asthma is a heterogeneous disease, characterised by the chronic inflammation of the airways, with a history of respiratory symptoms that change over time and intensity along with the fluctuating limitation of expiratory airflow. The purpose of asthma therapy is to regulate symptoms, reduce future risk and improve the quality of life (QoL). During the last decades, the effect of inhaled steroids and bronchodilators has been largely investigated as guideline-based pharmacological interventions. We present a review of existing data on non-pharmacological pulmonary rehabilitation in asthmatic patients.
Some research has recently shown the promising importance to non pharmacological asthma medication, such as lung rehabilitation, which demonstrates the ability to improve exercise, asthma control and quality control and reduces dyspnea, anxiety, depression and bronchial inflammation. In asthmaic patients, exercise tolerance, respiratory and QoL results in every stage of the disease have been positive for lung rehabilitation. Further information is however needed to better characterise rehabilitation programmes to improve clinical treatment in asthma.
Reference: https://journals.lww.com/co-allergy/Abstract/2020/02000/Pulmonary_rehabilitation__promising.13.aspx
